The European Commission has launched a public consultation aimed at improving the uniform application of requirements for Notified Bodies under the EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR).
This initiative aims to address inconsistencies, which have created uncertainty for manufacturers across the world.
What Is Being Proposed?
A key point of the proposal is that Notified Bodies may only issue quotations once they have received complete information from the manufacturer.
This means that manufacturers without a clearly appointed and documented EU Authorised Representative may face delays even at the quotation stage, impacting certification planning and timelines.
Next Steps
MDSS Insight
We support manufacturers as EU Authorised Representative and help ensure that all required information is in place early, avoiding unnecessary delays with Notified Bodies.

